98 related articles for article (PubMed ID: 2539818)
1. Effects of alpha-1-acid glycoprotein administration on propranolol binding and beta blockade in rats.
Keyler DE; Pentel PR
Biochem Pharmacol; 1989 Apr; 38(7):1163-8. PubMed ID: 2539818
[TBL] [Abstract][Full Text] [Related]
2. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats.
Pentel PR; Keyler DE
J Pharmacol Exp Ther; 1988 Sep; 246(3):1061-6. PubMed ID: 3418509
[TBL] [Abstract][Full Text] [Related]
3. Effect of serum, alpha-1 acid glycoprotein, lipoproteins and albumin on human mononuclear leucocyte beta-adrenoceptors.
Sager G; Sandnes D; Aakesson I; Jacobsen S
Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):193-203. PubMed ID: 3012942
[TBL] [Abstract][Full Text] [Related]
4. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
[TBL] [Abstract][Full Text] [Related]
5. Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderly.
Tenero DM; Bottorff MB; Burlew BS; Williams JB; Lalonde RL
J Cardiovasc Pharmacol; 1990 Nov; 16(5):702-7. PubMed ID: 1703590
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
Chauvelot-Moachon L; Delers F; Poüs C; Engler R; Tallet F; Giroud JP
J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective binding of beta-blockers to purified rat alpha 1-acid glycoprotein.
Murai-Kushiya M; Okada S; Kimura T; Hasegawa R
J Pharm Pharmacol; 1993 Mar; 45(3):225-8. PubMed ID: 8097783
[TBL] [Abstract][Full Text] [Related]
8. Effect of alpha 1-acidglycoprotein on myocardial uptake and pharmacodynamics of quinidine in perfused rat heart.
Huang JL; Morgan DJ
Biochem Pharmacol; 1993 Nov; 46(10):1705-11. PubMed ID: 8250956
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence studies of beta-adrenergic ligand binding to alpha 1-acid glycoprotein with 1-anilino-8-naphthalene sulfonate, isoprenaline, adrenaline and propranolol.
Johansen AK; Willassen NP; Sager G
Biochem Pharmacol; 1992 Feb; 43(4):725-9. PubMed ID: 1540225
[TBL] [Abstract][Full Text] [Related]
10. Propranolol disposition in the rat: variation in hepatic extraction with unbound drug fraction.
Gariépy L; Fenyves D; Villeneuve JP
J Pharm Sci; 1992 Mar; 81(3):255-8. PubMed ID: 1640364
[TBL] [Abstract][Full Text] [Related]
11. Effect of furosemide on plasma concentration and beta-blockade by propranolol.
Chiariello M; Volpe M; Rengo F; Trimarco B; Violini R; Ricciardelli B; Condorelli M
Clin Pharmacol Ther; 1979 Oct; 26(4):433-6. PubMed ID: 226305
[TBL] [Abstract][Full Text] [Related]
12. Binding of catecholamines to alpha-1 acid glycoprotein, albumin and lipoproteins in human serum.
Sager G; Bratlid H; Little C
Biochem Pharmacol; 1987 Nov; 36(21):3607-12. PubMed ID: 3675618
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and toxicity of high-dose human alpha 1-acid glycoprotein infusion in the rat.
Keyler DE; Pentel PR; Haughey DB
J Pharm Sci; 1987 Feb; 76(2):101-4. PubMed ID: 3572744
[TBL] [Abstract][Full Text] [Related]
14. Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.
Belpaire FM; Bogaert MG; Mugabo P; Rosseel MT
Br J Pharmacol; 1986 Jul; 88(3):697-705. PubMed ID: 2874859
[TBL] [Abstract][Full Text] [Related]
15. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG).
McNamara PJ; Brouwer KR; Gillespie MN
Biochem Pharmacol; 1986 Feb; 35(4):621-4. PubMed ID: 3947392
[TBL] [Abstract][Full Text] [Related]
16. Effect of the sialylation state of alpha 1-acid glycoprotein on propranolol binding.
Primozic S; McNamara PJ
J Pharm Sci; 1985 Apr; 74(4):473-5. PubMed ID: 3999012
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol.
Clements JD; Jamali F
Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884
[TBL] [Abstract][Full Text] [Related]
18. Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans.
Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ
Clin Pharmacol Ther; 1992 May; 51(5):549-54. PubMed ID: 1316824
[TBL] [Abstract][Full Text] [Related]
19. Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.
Steinkraus V; Nose M; Scholz H; Thormählen K
Br J Pharmacol; 1989 Feb; 96(2):441-9. PubMed ID: 2564293
[TBL] [Abstract][Full Text] [Related]
20. Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).
van Steeg TJ; Krekels EH; Freijer J; Danhof M; de Lange EC
J Pharm Sci; 2010 May; 99(5):2511-20. PubMed ID: 20020526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]